Chiralix是一家专业从事手性有机分子合成和供应的公司，Chiralix致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。
chiralix CX72515说明书
| CAS号 | 2981-96-6 |
|---|---|
| 化学名称 | 4,5,5-3甲基二氢呋喃-2(3H)-one |
| 分子式 | C 7 H 12 O 2 |
| 分子量 | 128.17 |
| 纯度 | >98% |
买chiralix，请认准chiralix代理商-上海金畔！
上海金畔chiralix书如下：
chiralix CX23880说明书
Product Details CX23880
| rac-GR24 | |
| A potent synthetic strigolactone analog.一种有效的合成独脚金内酯类似物。 |
|
| Chemical Name | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one |
| CAS Number | [76974-79-3] |
| Structure | |
| Molecular Formula | C17H14O5 |
| Molecular Weight | 298.29 |
| Purity | >98% |
| Order No. | Quantity | Price (EUR) |
|---|---|---|
| CX23880-5MG | 5 milligrams | € 240.00 |
| CX23880-20MG | 20 milligrams | € 750.00 |
| CX23880-100MG | 100 milligrams | € 1750.00 |
简要描述：Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。
详细介绍
产品咨询
Chiralix——手性分子专业供应商
Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。
公司主要产品：
1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。
| 货号 | 品名 | 化学名 | CAS号 | 分子量 | 分子式 | Synonyms | 纯度 | 包装 | 价格 |
| CX90418-1G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 1 G | 6200 |
| CX90418-2G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 2 G | 10600 |
| CX90418-5G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 5 G | 19900 |
| CX60325-200MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 200 MG | 4800 |
| CX60325-500MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 500 MG | 9800 |
| CX60325-1G | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 1 G | 16000 |
| CX80065-500MG | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 500 MG | 11200 |
| CX80065-1G | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 1 G | 18400 |
| CX90138-200MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 200 MG | 4800 |
| CX90138-500MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 500 MG | 9800 |
| CX90138-1G | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 1 G | 16000 |
| CX56292-500MG | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 500 MG | 6000 | |
| CX56292-1G | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 1 G | 9800 | |
| CX24022-500MG | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 500 MG | 6000 | |
| CX24022-1G | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 1 G | 9800 | |
| CX41399-1G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 1 G | 2200 | |
| CX41399-2G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 2 G | 3800 | |
| CX41399-5G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 5 G | 7200 | |
| CX64691-1G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 1 G | 2200 |
| CX64691-2G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 2 G | 3800 |
| CX64691-5G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 5 G | 7200 |
| CX97471-500MG | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 500 MG | 5200 |
| CX97471-1G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 1 G | 9000 |
| CX97471-2G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 2 G | 14800 |
| CX58692-1G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | |
| CX58692-2G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | |
| CX40529-1G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | |
| CX40529-2G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | |
| CX80916-500MG | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 500 MG | 6200 |
| CX80916-1G | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 1 G | 10800 |
| CX93851-100MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 100 MG | 3800 | |
| CX93851-500MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 500 MG | 12600 | |
| CX93851-1G | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 1 G | 19600 | |
| CX19922-1G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 1 G | 3000 | |
| CX19922-2G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 2 G | 5200 | |
| CX19922-5G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 5 G | 9800 | |
| CX62577-10MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 10 MG | 3600 | |
| CX62577-50MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 50 MG | 11800 | |
| CX25404-1G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 1 G | 3400 |
| CX25404-5G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 5 G | 12000 |
| CX23880-5MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 5 MG | 5000 | |
| CX23880-20MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 20 MG | 15000 | |
| CX23880-100MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 100 MG | 35000 | |
| CX38605-1G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 1 G | 7200 |
| CX38605-2G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 2 G | 12400 |
| CX59650-1G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 1 G | 3400 |
| CX59650-5G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 5 G | 12000 |
| CX94894-200MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 200 MG | 4400 |
| CX94894-500MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 500 MG | 9000 |
| CX94894-1G | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 1 G | 14600 |
| CX13745-1G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | |
| CX13745-2G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | |
| CX78500-1G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | |
| CX78500-2G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | |
| CX69324-500MG | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 500 MG | 6200 |
| CX69324-1G | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 1 G | 10800 |
| CX96388-1G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 1 G | 6200 |
| CX96388-2G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 2 G | 10600 |
| CX96388-5G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 5 G | 19900 |
| CX42388-1G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 1 G | 6200 |
| CX42388-2G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 2 G | 10600 |
| CX42388-5G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 5 G | 19900 |
| CX44656-500MG | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 500 MG | 9800 |
| CX44656-1G | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 1 G | 16000 |
| CX69013-500MG | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 500 MG | 9800 |
| CX69013-1G | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 1 G | 16000 |
| CX54783-500MG | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 500 MG | 9800 |
| CX54783-1G | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 1 G | 16000 |
| CX14845-500MG | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 500 MG | 9800 |
| CX14845-1G | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 1 G | 16000 |
| CX87818-500MG | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 500 MG | 11200 |
| CX87818-1G | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 1 G | 18400 |
| CX57816-500MG | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 500 MG | 10400 |
| CX57816-1G | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 1 G | 16800 |
| CX32424-200MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 200 MG | 4400 |
| CX32424-500MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 500 MG | 9000 |
| CX32424-1G | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 1 G | 14600 |
| CX80846-500MG | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 500 MG | 10400 |
| CX80846-1G | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 1 G | 16800 |
| CX52977-1G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 1 G | 2200 | |
| CX52977-2G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 2 G | 3800 | |
| CX52977-5G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 5 G | 7200 | |
| CX79659-1G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 1 G | 2200 | |
| CX79659-2G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 2 G | 3800 | |
| CX79659-5G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 5 G | 7200 | |
| CX56872-1G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 1 G | 2600 | |
| CX56872-2G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 2 G | 4400 | |
| CX56872-5G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 5 G | 8600 | |
| CX44048-1G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 1 G | 2200 |
| CX44048-2G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 2 G | 3800 |
| CX44048-5G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 5 G | 7200 |
| CX22855-1G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 1 G | 2600 |
| CX22855-2G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 2 G | 4400 |
| CX22855-5G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 5 G | 8600 |
| CX28901-1G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 1 G | 9000 |
| CX28901-2G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 2 G | 14800 |
| CX28344-1G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 1 G | 10400 |
| CX28344-2G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 2 G | 17200 |
| CX93005-1G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 1 G | 3400 |
| CX93005-5G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 5 G | 12000 |
| CX90286-200MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 200 MG | 4200 |
| CX90286-500MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 500 MG | 8800 |
| CX90286-1G | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 1 G | 15200 |
| CX44848-200MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
| CX44848-500MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
| CX44848-1G | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
| CX45124-500MG | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 500 MG | 6200 |
| CX45124-1G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 1 G | 10400 |
| CX45124-2G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 2 G | 17200 |
| CX43844-1G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 1 G | 2800 |
| CX43844-5G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 5 G | 10600 |
| CX66793-1G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 1 G | 2600 |
| CX66793-5G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 5 G | 9800 |
| CX90285-1G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 1 G | 2400 |
| CX90285-5G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 5 G | 9000 |
| CX32182-1G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 1 G | 2800 |
| CX32182-5G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 5 G | 10600 |
| CX33085-1G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 1 G | 2400 |
| CX33085-5G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 5 G | 9000 |
| CX37236-1G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 1 G | 2800 |
| CX37236-5G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 5 G | 10600 |
| CX81236-1G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 1 G | 2800 |
| CX81236-5G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 5 G | 10600 |
| CX84940-1G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 1 G | 2600 |
| CX84940-5G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 5 G | 9800 |
| CX81456-200MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
| CX81456-500MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
| CX81456-1G | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
| CX80632-1G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 1 G | 2800 |
| CX80632-5G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 5 G | 10600 |
| CX59871-1G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 1 G | 2600 |
| CX59871-5G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 5 G | 9800 |
| CX20625-1G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 1 G | 2600 |
| CX20625-5G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 5 G | 9800 |
| CX24163-1G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 1 G | 2800 |
| CX24163-5G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 5 G | 10600 |
| CX68680-1G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 1 G | 2800 |
| CX68680-5G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 5 G | 10600 |
| CX55921-1G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 1 G | 2800 |
| CX55921-5G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 5 G | 10600 |
| CX54776-200MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
| CX54776-500MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
| CX54776-1G | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
| CX46058-1G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 1 G | 3000 |
| CX46058-5G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 5 G | 11200 |
| CX44158-1G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 1 G | 3400 |
| CX44158-5G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 5 G | 12800 |
| CX27954-1G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 1 G | 2800 |
| CX27954-5G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 5 G | 10600 |
| CX56656-1G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 1 G | 2800 |
| CX56656-5G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 5 G | 10600 |
| CX16129-500MG | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 500 MG | 9000 |
| CX16129-1G | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 1 G | 14600 |
| CX65817-1G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 1 G | 9000 |
| CX65817-2G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 2 G | 14800 |
| CX19691-500MG | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 500 MG | 9000 |
| CX19691-1G | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 1 G | 14600 |
| CX59796-500MG | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 500 MG | 9000 |
| CX59796-1G | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 1 G | 14600 |
| CX79723-1G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 1 G | 12000 |
| CX79723-2G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 2 G | 19800 |
| CX32015-1G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 1 G | 2200 |
| CX32015-2G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 2 G | 3800 |
| CX32015-5G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 5 G | 7200 |
| CX81118-1G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 1 G | 3400 |
| CX81118-5G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 5 G | 12000 |
| CX19587-500MG | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 500 MG | 9000 |
| CX19587-1G | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 1 G | 14600 |
| CX28021-500MG | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 500 MG | 6000 | |
| CX28021-1G | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 1 G | 11000 | |
| CX72798-1G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 1 G | 6200 |
| CX72798-5G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 5 G | 23400 |
| CX93516-1G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 1 G | 5200 |
| CX93516-5G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 5 G | 19600 |
| CX76762-1G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 1 G | 3000 |
| CX76762-5G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 5 G | 11200 |
| CX53333-1G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 1 G | 9200 |
| CX53333-2G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 2 G | 16400 |
| CX83245-1G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 1 G | 5400 |
| CX83245-5G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 5 G | 20400 |
| CX13425-1G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 1 G | 7200 |
| CX13425-5G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 5 G | 27200 |
| CX29937-1G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 1 G | 6400 |
| CX29937-5G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 5 G | 24200 |
| CX85233-1G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 1 G | 2600 |
| CX85233-5G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 5 G | 9800 |
| CX37313-1G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 1 G | 3000 |
| CX37313-5G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 5 G | 11200 |
| CX95405-1G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 1 G | 3200 |
| CX95405-5G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 5 G | 12000 |
| CX57717-1G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 1 G | 2600 |
| CX57717-5G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 5 G | 9800 |
| CX79807-1G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 1 G | 3200 |
| CX79807-5G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 5 G | 12000 |
| CX94556-1G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 1 G | 3200 |
| CX94556-5G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 5 G | 12000 |
| CX83100-1G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 1 G | 4000 |
| CX83100-5G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 5 G | 15000 |
| CX48141-1G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 1 G | 2600 |
| CX48141-5G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 5 G | 9800 |
| CX93426-1G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 1 G | 4000 |
| CX93426-5G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 5 G | 15000 |
| CX24279-1G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 1 G | 3600 |
| CX24279-5G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 5 G | 13600 |
| CX78063-1G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 1 G | 2800 |
| CX78063-5G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 5 G | 10600 |
| CX30547-1G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 1 G | 6600 |
| CX30547-5G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 5 G | 25000 |
| CX78942-1G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 1 G | 5600 |
| CX78942-5G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 5 G | 21200 |
| CX61332-1G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 1 G | 9000 |
| CX61332-2G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 2 G | 16000 |
| CX56925-1G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 1 G | 4000 |
| CX56925-5G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 5 G | 15000 |
| CX22361-1G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 1 G | 9000 |
| CX22361-2G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 2 G | 14800 |
| CX52265-1G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 1 G | 10400 |
| CX52265-2G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 2 G | 17200 |
| CX71813-1G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 1 G | 3000 |
| CX71813-5G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 5 G | 11200 |
| CX40608-5G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 5 G | 6000 | |
| CX40608-10G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 10 G | 11000 | |
| CX23053-500MG | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | |
| CX23053-1G | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | |
| CX63523-500MG | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | |
| CX63523-1G | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | |
| CX69091-500MG | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | |
| CX69091-1G | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | |
| CX76358-500MG | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | |
| CX76358-1G | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | |
| CX55029-2MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 2 MG | 12000 | |
| CX55029-5MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 5 MG | 24000 | |
| CX45120-1G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 1 G | 4000 | |
| CX45120-2G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 2 G | 9000 | |
| CX45120-5G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 5 G | 15000 | |
| CX57163-2MG | 13C6-cereulide | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | >95% | 2 MG | 24000 | |
| CX64158-1G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 1 G | 4000 |
| CX64158-2G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 2 G | 7200 |
| CX64158-5G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 5 G | 15000 |
| CX80044-250MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 250 MG | 7600 | |
| CX80044-500MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 500 MG | 14000 | |
| CX80044-1G | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 1 G | 25000 | |
| CX67830-250MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 250 MG | 7800 | |
| CX67830-500MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 500 MG | 14400 | |
| CX67830-1G | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 1 G | 26000 | |
| CX18326-1G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 1 G | 5000 | |
| CX18326-2G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 2 G | 9000 | |
| CX18326-5G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 5 G | 19000 | |
| CX59077-1G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 1 G | 6000 | |
| CX59077-2G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 2 G | 10800 | |
| CX59077-5G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 5 G | 22000 | |
| CX48623-1G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 1 G | 5000 | |
| CX48623-2G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 2 G | 9000 | |
| CX48623-5G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 5 G | 19000 | |
| CX55361-500MG | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 500 MG | 6000 | |
| CX55361-1G | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 1 G | 10800 | |
| CX84944-1G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 1 G | 4000 | |
| CX84944-2G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 2 G | 7200 | |
| CX84944-5G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 5 G | 15000 | |
| CX69359-5G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 5 G | 6000 |
| CX69359-10G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 10 G | 11000 |
| CX31309-5G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 5 G | 6600 |
| CX31309-10G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 10 G | 11800 |
| CX98490-5G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 5 G | 6000 | |
| CX98490-10G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 10 G | 11000 | |
| CX65527-1G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 1 G | 2800 | |
| CX65527-5G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 5 G | 10600 | |
| CX65527-10G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 10 G | 17000 | |
| CX61074-200MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 |
| CX61074-500MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 |
| CX61074-1G | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 |
| CX39389-200MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 |
| CX39389-500MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 |
| CX39389-1G | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 |
| CX80391-200MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 |
| CX80391-500MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 |
| CX80391-1G | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 |
| CX82876-200MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 |
| CX82876-500MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 |
| CX82876-1G | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 |
| CX93488-1MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 1 MG | 4000 |
| CX93488-5MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 5 MG | 15000 |
| CX64382-1MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 1 MG | 5000 | |
| CX64382-5MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 5 MG | 18800 | |
| CX88057-10MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 10 MG | 3600 | |
| CX88057-50MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 50 MG | 11800 | |
| CX42450-200MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 |
| CX42450-500MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 |
| CX42450-1G | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 |
| CX35419-200MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 |
| CX35419-500MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 |
| CX35419-1G | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 |
| CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 |
| CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 |
| CX11583-1G | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 |
| CX92224-200MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 |
| CX92224-500MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 |
| CX92224-1G | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 |
| CX81018-500MG | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 |
| CX81018-1G | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 |
| CX85919-500MG | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 |
| CX85919-1G | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 |
| CX98774-500MG | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 |
| CX98774-1G | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 |
| CX33604-500MG | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 |
| CX33604-1G | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 |
| CX82946-500MG | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 |
| CX82946-1G | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 |
| CX86231-500MG | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 |
| CX86231-1G | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 |
| CX15046-500MG | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 |
| CX15046-1G | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 |
| CX30199-500MG | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 |
| CX30199-1G | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 |
| CX20422-1ML | cereulide (50 µg/mL in acetonitrile) | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) | Not available | 1153.40 | C57 H96 N6 O18 | cereulide stock solution | >95% | 1 ML | 5000 |
| CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | 13C6-cereulide stock solution | >95% | 1 ML | 5000 |
| CX18112-1G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 3000 | |
| CX18112-5G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 7400 | |
| CX18112-10G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 10 G | 13200 | |
| CX95981-5G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 5 G | 2200 |
| CX95981-10G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 10 G | 4000 |
| CX95981-25G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 25 G | 8400 |
| CX62483-1G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | |
| CX62483-2G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | |
| CX62483-5G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | |
| CX80461-1G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | |
| CX80461-2G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | |
| CX80461-5G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | |
| CX27597-1G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 1 G | 2600 | |
| CX27597-5G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 5 G | 9800 | |
| CX50506-10MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 10 MG | 3600 | |
| CX50506-50MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 50 MG | 13800 | |
| CX50506-100MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 100 MG | 23000 | |
| CX95469-10MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 10 MG | 3000 |
| CX95469-50MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 50 MG | 11400 |
| CX95469-100MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 100 MG | 19600 |
| CX75854-10MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 10 MG | 3000 | |
| CX75854-50MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 50 MG | 11400 | |
| CX75854-100MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 100 MG | 19600 | |
| CX52612-10MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 10 MG | 3000 | |
| CX52612-50MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 50 MG | 11400 | |
| CX52612-100MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 100 MG | 19600 | |
| CX93797-10G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 10 G | 6000 |
| CX93797-25G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 25 G | 13000 |
| CX29693-10G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 10 G | 6000 |
| CX29693-25G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 25 G | 13000 |
Chiralix2024年价格表
Chiralix致力于通过提供一系列独t的构建块、参考标准品、代谢物、杂质、稳定同位素标记的化合物（2H、13C和15N）等，支持全球的生命科学研究人员。
Chiralix——荷兰手性分子专业供应商，致力于制药公司及生命科学研究领域的实验室研究用手性分子的生产和研发。除了提供大量的手性分子成品，我们还提供的研发服务，如复杂有机分子的合成等。
Chiralix特色产品有：Cereulide & 13C6-Cereulide、Labelled Compounds、Strigolactones & Analogs、Chromo- & Fluorogenic Amino Acids等。
特别告知：为保证产品质量与良好性能，所以在购买相应产品的同时我司会收取一定量的运输费用！！！本次报价有效时间为2024年1月9日—2024年12月14日。
| 货号 | 品名 | 规格 | 价格 | 品牌 | 货期 | 价格来源 |
| CX23880-5MG | rac-GR24 | 5MG | 4752.00 | Chiralix | 4周 | 上海金畔 |
| CX55029-2MG | cereulide | 2MG | 11880.00 | Chiralix | 4周 | 上海金畔 |
| CX27716-5MG | KAR1 | 5MG | 6930.00 | Chiralix | 4周 | 上海金畔 |
| CX23880-20MG | rac-GR24 | 20MG | 14850.00 | Chiralix | 4周 | 上海金畔 |
| CX34065-1MG | 25-OH vitamin D3-DPEG4-Biotin | 1MG | 7722.00 | Chiralix | 4周 | 上海金畔 |
| CX93488-1MG | (±)-sorgolactone | 1MG | 3960.00 | Chiralix | 4周 | 上海金畔 |
| CX57163-2MG | 13C6-cereulide | 2MG | 23760.00 | Chiralix | 4周 | 上海金畔 |
| CX94877-10MG | KAR2 | 10MG | 8514.00 | Chiralix | 4周 | 上海金畔 |
| CX94877-5MG | KAR2 | 5MG | 4752.00 | Chiralix | 4周 | 上海金畔 |
| CX27716-10MG | KAR1 | 10MG | 12474.00 | Chiralix | 4周 | 上海金畔 |
| CX23911-5MG | (±)-2'-epi-5-deoxystrigol | 5MG | 18612.00 | Chiralix | 4周 | 上海金畔 |
| CX23911-1MG | (±)-2'-epi-5-deoxystrigol | 1MG | 4950.00 | Chiralix | 4周 | 上海金畔 |
| CX55029-5MG | cereulide | 5MG | 23760.00 | Chiralix | 4周 | 上海金畔 |
| CX94973-5MG | 25-Hydroxyvitamin D3 3-Hemisuccinate | 5MG | 5742.00 | Chiralix | 4周 | 上海金畔 |
| CX94224-10MG | Abamine SG oxalic acid salt | 10MG | 2970.00 | Chiralix | 4周 | 上海金畔 |
| CX93488-5MG | (±)-sorgolactone | 5MG | 14850.00 | Chiralix | 4周 | 上海金畔 |
| CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | 1ML | 4950.00 | Chiralix | 4周 | 上海金畔 |
| CX64382-1MG | (±)-strigol | 1MG | 4950.00 | Chiralix | 4周 | 上海金畔 |
| CX48771-5MG | 4'-hydroxydiclofenac-13C6 | 5MG | 9900.00 | Chiralix | 4周 | 上海金畔 |
| CX27716-25MG | KAR1 | 25MG | 26730.00 | Chiralix | 4周 | 上海金畔 |
| CX23880-100MG | rac-GR24 | 100MG | 34650.00 | Chiralix | 4周 | 上海金畔 |
| CX10104-5MG | Erythromycin-D3 | 5MG | 9900.00 | Chiralix | 4周 | 上海金畔 |
| CX10104-10MG | Erythromycin-D3 | 10MG | 15840.00 | Chiralix | 4周 | 上海金畔 |
| CX10104-25MG | Erythromycin-D3 | 25MG | 29700.00 | Chiralix | 4周 | 上海金畔 |
| CX10388-1MG | Droxidopa Impurity M hydrochloride | 1MG | 7920.00 | Chiralix | 4周 | 上海金畔 |
| CX10388-5MG | Droxidopa Impurity M hydrochloride | 5MG | 31680.00 | Chiralix | 4周 | 上海金畔 |
| CX10388-10MG | Droxidopa Impurity M hydrochloride | 10MG | 57420.00 | Chiralix | 4周 | 上海金畔 |
| CX11158-5MG | OSI-420 | 5MG | 12870.00 | Chiralix | 4周 | 上海金畔 |
| CX11158-10MG | OSI-420 | 10MG | 19800.00 | Chiralix | 4周 | 上海金畔 |
| CX11158-25MG | OSI-420 | 25MG | 39600.00 | Chiralix | 4周 | 上海金畔 |
| CX11263-10MG | Thiophene-2-carboxylic-13C acid | 10MG | 11880.00 | Chiralix | 4周 | 上海金畔 |
| CX11263-25MG | Thiophene-2-carboxylic-13C acid | 25MG | 21780.00 | Chiralix | 4周 | 上海金畔 |
| CX11263-50MG | Thiophene-2-carboxylic-13C acid | 50MG | 35640.00 | Chiralix | 4周 | 上海金畔 |
| CX11340-10MG | 4'-phosphopantetheine di-sodium salt | 10MG | 15444.00 | Chiralix | 4周 | 上海金畔 |
| CX11340-25MG | 4'-phosphopantetheine di-sodium salt | 25MG | 29700.00 | Chiralix | 4周 | 上海金畔 |
| CX11340-50MG | 4'-phosphopantetheine di-sodium salt | 50MG | 37620.00 | Chiralix | 4周 | 上海金畔 |
| CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | 200MG | 4752.00 | Chiralix | 4周 | 上海金畔 |
| CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | 500MG | 9702.00 | Chiralix | 4周 | 上海金畔 |
| CX11583-1G | (R)-beta2-homophenylalanine HCl salt | 1G | 15840.00 | Chiralix | 4周 | 上海金畔 |
| CX12139-1MG | Hydroxyitraconazole D8 | 1MG | 3762.00 | Chiralix | 4周 | 上海金畔 |
| CX12139-5MG | Hydroxyitraconazole D8 | 5MG | 13860.00 | Chiralix | 4周 | 上海金畔 |
| CX12139-10MG | Hydroxyitraconazole D8 | 10MG | 23760.00 | Chiralix | 4周 | 上海金畔 |
| CX12657-5MG | Diltiazem D6 hydrochloride | 5MG | 5940.00 | Chiralix | 4周 | 上海金畔 |
| CX12657-10MG | Diltiazem D6 hydrochloride | 10MG | 9900.00 | Chiralix | 4周 | 上海金畔 |
| CX12657-25MG | Diltiazem D6 hydrochloride | 25MG | 17820.00 | Chiralix | 4周 | 上海金畔 |
| CX12732-5MG | (R)-Terbutaline hemisulfate | 5MG | 6534.00 | Chiralix | 4周 | 上海金畔 |
| CX12732-10MG | (R)-Terbutaline hemisulfate | 10MG | 10494.00 | Chiralix | 4周 | 上海金畔 |
| CX12732-25MG | (R)-Terbutaline hemisulfate | 25MG | 19602.00 | Chiralix | 4周 | 上海金畔 |
| CX13001-1MG | 3,3',5-triiodo-L-thyronine-13C6 | 1MG | 5940.00 | Chiralix | 4周 | 上海金畔 |
| CX13001-5MG | 3,3',5-triiodo-L-thyronine-13C6 | 5MG | 19404.00 | Chiralix | 4周 | 上海金畔 |
关键词：Chiralix、有机分子合成、叠氮酸、氨基醇、手性分子
简要描述：Chiralix代理，Chiralix中国代理，Chiralix上海代理，Chiralix代理，ChiralixChiralix专业代理-上海金畔生物科技有限公司，具体产品信息欢迎电询：021-50837765
详细介绍
产品咨询
Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。
产品列表
| 货号 | 品名 | 化学名 | CAS号 | 分子量 | 分子式 | Synonyms | 纯度 | 包装 | 价格 | 品牌 |
| CX90418-1G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 1 G | 6200 | chiralix |
| CX90418-2G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 2 G | 10600 | chiralix |
| CX90418-5G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 5 G | 19900 | chiralix |
| CX60325-200MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 200 MG | 4800 | chiralix |
| CX60325-500MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX60325-1G | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX80065-500MG | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 500 MG | 11200 | chiralix |
| CX80065-1G | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 1 G | 18400 | chiralix |
| CX90138-200MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 200 MG | 4800 | chiralix |
| CX90138-500MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX90138-1G | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX56292-500MG | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 500 MG | 6000 | chiralix | |
| CX56292-1G | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 1 G | 9800 | chiralix | |
| CX24022-500MG | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 500 MG | 6000 | chiralix | |
| CX24022-1G | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 1 G | 9800 | chiralix | |
| CX41399-1G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 1 G | 2200 | chiralix | |
| CX41399-2G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 2 G | 3800 | chiralix | |
| CX41399-5G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 5 G | 7200 | chiralix | |
| CX64691-1G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 1 G | 2200 | chiralix |
| CX64691-2G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 2 G | 3800 | chiralix |
| CX64691-5G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 5 G | 7200 | chiralix |
| CX97471-500MG | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 500 MG | 5200 | chiralix |
| CX97471-1G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 1 G | 9000 | chiralix |
| CX97471-2G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 2 G | 14800 | chiralix |
| CX58692-1G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | chiralix | |
| CX58692-2G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | chiralix | |
| CX40529-1G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | chiralix | |
| CX40529-2G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | chiralix | |
| CX80916-500MG | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 500 MG | 6200 | chiralix |
| CX80916-1G | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 1 G | 10800 | chiralix |
| CX93851-100MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 100 MG | 3800 | chiralix | |
| CX93851-500MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 500 MG | 12600 | chiralix | |
| CX93851-1G | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 1 G | 19600 | chiralix | |
| CX19922-1G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 1 G | 3000 | chiralix | |
| CX19922-2G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 2 G | 5200 | chiralix | |
| CX19922-5G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 5 G | 9800 | chiralix | |
| CX62577-10MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 10 MG | 3600 | chiralix | |
| CX62577-50MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 50 MG | 11800 | chiralix | |
| CX25404-1G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 1 G | 3400 | chiralix |
| CX25404-5G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 5 G | 12000 | chiralix |
| CX23880-5MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 5 MG | 5000 | chiralix | |
| CX23880-20MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 20 MG | 15000 | chiralix | |
| CX23880-100MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 100 MG | 35000 | chiralix | |
| CX38605-1G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 1 G | 7200 | chiralix |
| CX38605-2G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 2 G | 12400 | chiralix |
| CX59650-1G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 1 G | 3400 | chiralix |
| CX59650-5G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 5 G | 12000 | chiralix |
| CX94894-200MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 200 MG | 4400 | chiralix |
| CX94894-500MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 500 MG | 9000 | chiralix |
| CX94894-1G | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 1 G | 14600 | chiralix |
| CX13745-1G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | chiralix | |
| CX13745-2G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | chiralix | |
| CX78500-1G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | chiralix | |
| CX78500-2G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | chiralix | |
| CX69324-500MG | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 500 MG | 6200 | chiralix |
| CX69324-1G | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 1 G | 10800 | chiralix |
| CX96388-1G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 1 G | 6200 | chiralix |
| CX96388-2G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 2 G | 10600 | chiralix |
| CX96388-5G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 5 G | 19900 | chiralix |
| CX42388-1G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 1 G | 6200 | chiralix |
| CX42388-2G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 2 G | 10600 | chiralix |
| CX42388-5G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 5 G | 19900 | chiralix |
| CX44656-500MG | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX44656-1G | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX69013-500MG | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX69013-1G | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX54783-500MG | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX54783-1G | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX14845-500MG | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX14845-1G | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX87818-500MG | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 500 MG | 11200 | chiralix |
| CX87818-1G | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 1 G | 18400 | chiralix |
| CX57816-500MG | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 500 MG | 10400 | chiralix |
| CX57816-1G | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 1 G | 16800 | chiralix |
| CX32424-200MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 200 MG | 4400 | chiralix |
| CX32424-500MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 500 MG | 9000 | chiralix |
| CX32424-1G | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 1 G | 14600 | chiralix |
| CX80846-500MG | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 500 MG | 10400 | chiralix |
| CX80846-1G | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 1 G | 16800 | chiralix |
| CX52977-1G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 1 G | 2200 | chiralix | |
| CX52977-2G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 2 G | 3800 | chiralix | |
| CX52977-5G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 5 G | 7200 | chiralix | |
| CX79659-1G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 1 G | 2200 | chiralix | |
| CX79659-2G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 2 G | 3800 | chiralix | |
| CX79659-5G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 5 G | 7200 | chiralix | |
| CX56872-1G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 1 G | 2600 | chiralix | |
| CX56872-2G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 2 G | 4400 | chiralix | |
| CX56872-5G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 5 G | 8600 | chiralix | |
| CX44048-1G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 1 G | 2200 | chiralix |
| CX44048-2G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 2 G | 3800 | chiralix |
| CX44048-5G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 5 G | 7200 | chiralix |
| CX22855-1G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 1 G | 2600 | chiralix |
| CX22855-2G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 2 G | 4400 | chiralix |
| CX22855-5G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 5 G | 8600 | chiralix |
| CX28901-1G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 1 G | 9000 | chiralix |
| CX28901-2G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 2 G | 14800 | chiralix |
| CX28344-1G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 1 G | 10400 | chiralix |
| CX28344-2G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 2 G | 17200 | chiralix |
| CX93005-1G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 1 G | 3400 | chiralix |
| CX93005-5G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 5 G | 12000 | chiralix |
| CX90286-200MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 200 MG | 4200 | chiralix |
| CX90286-500MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 500 MG | 8800 | chiralix |
| CX90286-1G | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 1 G | 15200 | chiralix |
| CX44848-200MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX44848-500MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX44848-1G | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX45124-500MG | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 500 MG | 6200 | chiralix |
| CX45124-1G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 1 G | 10400 | chiralix |
| CX45124-2G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 2 G | 17200 | chiralix |
| CX43844-1G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX43844-5G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX66793-1G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX66793-5G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX90285-1G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 1 G | 2400 | chiralix |
| CX90285-5G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 5 G | 9000 | chiralix |
| CX32182-1G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX32182-5G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX33085-1G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 1 G | 2400 | chiralix |
| CX33085-5G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 5 G | 9000 | chiralix |
| CX37236-1G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX37236-5G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX81236-1G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 1 G | 2800 | chiralix |
| CX81236-5G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 5 G | 10600 | chiralix |
| CX84940-1G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX84940-5G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX81456-200MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX81456-500MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX81456-1G | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX80632-1G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX80632-5G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX59871-1G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX59871-5G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX20625-1G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX20625-5G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX24163-1G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX24163-5G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX68680-1G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX68680-5G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX55921-1G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX55921-5G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX54776-200MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX54776-500MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX54776-1G | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX46058-1G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX46058-5G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX44158-1G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 1 G | 3400 | chiralix |
| CX44158-5G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 5 G | 12800 | chiralix |
| CX27954-1G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX27954-5G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX56656-1G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX56656-5G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX16129-500MG | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX16129-1G | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX65817-1G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX65817-2G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 2 G | 14800 | chiralix |
| CX19691-500MG | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX19691-1G | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX59796-500MG | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX59796-1G | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX79723-1G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 1 G | 12000 | chiralix |
| CX79723-2G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 2 G | 19800 | chiralix |
| CX32015-1G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 1 G | 2200 | chiralix |
| CX32015-2G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 2 G | 3800 | chiralix |
| CX32015-5G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 5 G | 7200 | chiralix |
| CX81118-1G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 1 G | 3400 | chiralix |
| CX81118-5G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 5 G | 12000 | chiralix |
| CX19587-500MG | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX19587-1G | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX28021-500MG | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 500 MG | 6000 | chiralix | |
| CX28021-1G | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 1 G | 11000 | chiralix | |
| CX72798-1G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 1 G | 6200 | chiralix |
| CX72798-5G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 5 G | 23400 | chiralix |
| CX93516-1G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 1 G | 5200 | chiralix |
| CX93516-5G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 5 G | 19600 | chiralix |
| CX76762-1G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX76762-5G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX53333-1G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 1 G | 9200 | chiralix |
| CX53333-2G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 2 G | 16400 | chiralix |
| CX83245-1G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 1 G | 5400 | chiralix |
| CX83245-5G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 5 G | 20400 | chiralix |
| CX13425-1G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 1 G | 7200 | chiralix |
| CX13425-5G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 5 G | 27200 | chiralix |
| CX29937-1G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 1 G | 6400 | chiralix |
| CX29937-5G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 5 G | 24200 | chiralix |
| CX85233-1G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX85233-5G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX37313-1G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX37313-5G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX95405-1G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 1 G | 3200 | chiralix |
| CX95405-5G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 5 G | 12000 | chiralix |
| CX57717-1G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 1 G | 2600 | chiralix |
| CX57717-5G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 5 G | 9800 | chiralix |
| CX79807-1G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 1 G | 3200 | chiralix |
| CX79807-5G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 5 G | 12000 | chiralix |
| CX94556-1G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 1 G | 3200 | chiralix |
| CX94556-5G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 5 G | 12000 | chiralix |
| CX83100-1G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 1 G | 4000 | chiralix |
| CX83100-5G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 5 G | 15000 | chiralix |
| CX48141-1G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX48141-5G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX93426-1G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 1 G | 4000 | chiralix |
| CX93426-5G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 5 G | 15000 | chiralix |
| CX24279-1G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 1 G | 3600 | chiralix |
| CX24279-5G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 5 G | 13600 | chiralix |
| CX78063-1G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX78063-5G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX30547-1G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 1 G | 6600 | chiralix |
| CX30547-5G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 5 G | 25000 | chiralix |
| CX78942-1G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 1 G | 5600 | chiralix |
| CX78942-5G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 5 G | 21200 | chiralix |
| CX61332-1G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX61332-2G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 2 G | 16000 | chiralix |
| CX56925-1G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 1 G | 4000 | chiralix |
| CX56925-5G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 5 G | 15000 | chiralix |
| CX22361-1G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX22361-2G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 2 G | 14800 | chiralix |
| CX52265-1G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 1 G | 10400 | chiralix |
| CX52265-2G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 2 G | 17200 | chiralix |
| CX71813-1G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX71813-5G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX40608-5G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 5 G | 6000 | chiralix | |
| CX40608-10G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 10 G | 11000 | chiralix | |
| CX23053-500MG | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | chiralix | |
| CX23053-1G | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | chiralix | |
| CX63523-500MG | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | chiralix | |
| CX63523-1G | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | chiralix | |
| CX69091-500MG | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | chiralix | |
| CX69091-1G | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | chiralix | |
| CX76358-500MG | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | chiralix | |
| CX76358-1G | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | chiralix | |
| CX55029-2MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 2 MG | 12000 | chiralix | |
| CX55029-5MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 5 MG | 24000 | chiralix | |
| CX45120-1G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 1 G | 4000 | chiralix | |
| CX45120-2G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 2 G | 9000 | chiralix | |
| CX45120-5G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 5 G | 15000 | chiralix | |
| CX57163-2MG | 13C6-cereulide | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | >95% | 2 MG | 24000 | chiralix | |
| CX64158-1G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 1 G | 4000 | chiralix |
| CX64158-2G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 2 G | 7200 | chiralix |
| CX64158-5G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 5 G | 15000 | chiralix |
| CX80044-250MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 250 MG | 7600 | chiralix | |
| CX80044-500MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 500 MG | 14000 | chiralix | |
| CX80044-1G | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 1 G | 25000 | chiralix | |
| CX67830-250MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 250 MG | 7800 | chiralix | |
| CX67830-500MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 500 MG | 14400 | chiralix | |
| CX67830-1G | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 1 G | 26000 | chiralix | |
| CX18326-1G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 1 G | 5000 | chiralix | |
| CX18326-2G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 2 G | 9000 | chiralix | |
| CX18326-5G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 5 G | 19000 | chiralix | |
| CX59077-1G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 1 G | 6000 | chiralix | |
| CX59077-2G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 2 G | 10800 | chiralix | |
| CX59077-5G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 5 G | 22000 | chiralix | |
| CX48623-1G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 1 G | 5000 | chiralix | |
| CX48623-2G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 2 G | 9000 | chiralix | |
| CX48623-5G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 5 G | 19000 | chiralix | |
| CX55361-500MG | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 500 MG | 6000 | chiralix | |
| CX55361-1G | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 1 G | 10800 | chiralix | |
| CX84944-1G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 1 G | 4000 | chiralix | |
| CX84944-2G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 2 G | 7200 | chiralix | |
| CX84944-5G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 5 G | 15000 | chiralix | |
| CX69359-5G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 5 G | 6000 | chiralix |
| CX69359-10G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 10 G | 11000 | chiralix |
| CX31309-5G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 5 G | 6600 | chiralix |
| CX31309-10G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 10 G | 11800 | chiralix |
| CX98490-5G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 5 G | 6000 | chiralix | |
| CX98490-10G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 10 G | 11000 | chiralix | |
| CX65527-1G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 1 G | 2800 | chiralix | |
| CX65527-5G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 5 G | 10600 | chiralix | |
| CX65527-10G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 10 G | 17000 | chiralix | |
| CX61074-200MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX61074-500MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX61074-1G | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX39389-200MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX39389-500MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX39389-1G | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX80391-200MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX80391-500MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX80391-1G | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX82876-200MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX82876-500MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX82876-1G | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX93488-1MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 1 MG | 4000 | chiralix |
| CX93488-5MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 5 MG | 15000 | chiralix |
| CX64382-1MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 1 MG | 5000 | chiralix | |
| CX64382-5MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 5 MG | 18800 | chiralix | |
| CX88057-10MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 10 MG | 3600 | chiralix | |
| CX88057-50MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 50 MG | 11800 | chiralix | |
| CX42450-200MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX42450-500MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX42450-1G | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX35419-200MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX35419-500MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX35419-1G | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX11583-1G | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX92224-200MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX92224-500MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX92224-1G | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX81018-500MG | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 | chiralix |
| CX81018-1G | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 | chiralix |
| CX85919-500MG | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 | chiralix |
| CX85919-1G | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 | chiralix |
| CX98774-500MG | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 | chiralix |
| CX98774-1G | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 | chiralix |
| CX33604-500MG | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 | chiralix |
| CX33604-1G | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 | chiralix |
| CX82946-500MG | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 | chiralix |
| CX82946-1G | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 | chiralix |
| CX86231-500MG | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 | chiralix |
| CX86231-1G | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 | chiralix |
| CX15046-500MG | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 | chiralix |
| CX15046-1G | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 | chiralix |
| CX30199-500MG | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 | chiralix |
| CX30199-1G | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 | chiralix |
| CX20422-1ML | cereulide (50 µg/mL in acetonitrile) | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) | Not available | 1153.40 | C57 H96 N6 O18 | cereulide stock solution | >95% | 1 ML | 5000 | chiralix |
| CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | 13C6-cereulide stock solution | >95% | 1 ML | 5000 | chiralix |
| CX18112-1G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 3000 | chiralix | |
| CX18112-5G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 7400 | chiralix | |
| CX18112-10G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 10 G | 13200 | chiralix | |
| CX95981-5G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 5 G | 2200 | chiralix |
| CX95981-10G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 10 G | 4000 | chiralix |
| CX95981-25G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 25 G | 8400 | chiralix |
| CX62483-1G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | chiralix | |
| CX62483-2G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | chiralix | |
| CX62483-5G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | chiralix | |
| CX80461-1G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | chiralix | |
| CX80461-2G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | chiralix | |
| CX80461-5G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | chiralix | |
| CX27597-1G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 1 G | 2600 | chiralix | |
| CX27597-5G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 5 G | 9800 | chiralix | |
| CX50506-10MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 10 MG | 3600 | chiralix | |
| CX50506-50MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 50 MG | 13800 | chiralix | |
| CX50506-100MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 100 MG | 23000 | chiralix | |
| CX95469-10MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 10 MG | 3000 | chiralix |
| CX95469-50MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 50 MG | 11400 | chiralix |
| CX95469-100MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 100 MG | 19600 | chiralix |
| CX75854-10MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 10 MG | 3000 | chiralix | |
| CX75854-50MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 50 MG | 11400 | chiralix | |
| CX75854-100MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 100 MG | 19600 | chiralix | |
| CX52612-10MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 10 MG | 3000 | chiralix | |
| CX52612-50MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 50 MG | 11400 | chiralix | |
| CX52612-100MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 100 MG | 19600 | chiralix | |
| CX93797-10G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 10 G | 6000 | chiralix |
| CX93797-25G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 25 G | 13000 | chiralix |
| CX29693-10G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 10 G | 6000 | chiralix |
| CX29693-25G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 25 G | 13000 | chiralix |
公司主要产品：
1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。
2、N-BOC保护的氨基酸骨架类
3、N-CBZ 保护的氨基酸骨架类
4、N-FMOC 保护的氨基酸骨架类
5、AZIDO氨基酸骨架类
6、β2氨基酸骨架类
7、FMOC保护的β2氨基酸骨架类
8、CHROMOGENIC 及FLUOROGENIC氨基酸
9、氨基乙醇及其衍生产品
10、CEREULIDE & 13C6-CEREULIDE（致吐毒素及其衍生品）
11、STRIGOLACTONES & ANALOGUES（独脚金内酯及其类似物）
12、其它产品
更多产品请访问：http://www.chiralix.com/
世界*实验材料供应商Chiralix正式上海金畔为其中国代理，Chiralix在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔一直秉承为中国科研客户带来的产品，的服务， Chiralix就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Chiralix中国代理，Chiralix上海代理，Chiralix北京代理，Chiralix广东代理，Chiralix江苏代理 Chiralix湖北代理, Chiralix天津, Chiralix黑龙江代理, Chiralix内蒙古代理, Chiralix吉林代理, Chiralix福建代理, Chiralix江苏代理, Chiralix浙江代理, Chiralix四川代理,
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;……几十家国外公司代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend….等*批发
chiralix代理
Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。
公司主要产品：
1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。
chiralix常卖产品：
| 货号 | 品名 | 规格 | 品牌 |
| CX10104-5MG | Erythromycin-D3 | 5MG | Chiralix |
| CX10104-10MG | Erythromycin-D3 | 10MG | Chiralix |
| CX10104-25MG | Erythromycin-D3 | 25MG | Chiralix |
| CX11158-5MG | OSI-420 | 5MG | Chiralix |
| CX11158-10MG | OSI-420 | 10MG | Chiralix |
| CX11158-25MG | OSI-420 | 25MG | Chiralix |
| CX11263-10MG | Thiophene-2-carboxylic-13C acid | 10MG | Chiralix |
| CX11263-25MG | Thiophene-2-carboxylic-13C acid | 25MG | Chiralix |
| CX11263-50MG | Thiophene-2-carboxylic-13C acid | 50MG | Chiralix |
| CX11340-10MG | 4'-phosphopantetheine di-sodium salt | 10MG | Chiralix |
| CX11340-25MG | 4'-phosphopantetheine di-sodium salt | 25MG | Chiralix |
| CX11340-50MG | 4'-phosphopantetheine di-sodium salt | 50MG | Chiralix |
| CX11547-5MG | Zolpidem D6 | 5MG | Chiralix |
| CX11547-10MG | Zolpidem D6 | 10MG | Chiralix |
| CX11547-25MG | Zolpidem D6 | 25MG | Chiralix |
| CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | 200MG | Chiralix |
| CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | 500MG | Chiralix |
| CX11583-1G | (R)-beta2-homophenylalanine HCl salt | 1G | Chiralix |
| CX12139-1MG | Hydroxyitraconazole D8 | 1MG | Chiralix |
| CX12139-5MG | Hydroxyitraconazole D8 | 5MG | Chiralix |
| CX12139-10MG | Hydroxyitraconazole D8 | 10MG | Chiralix |
| CX12657-5MG | Diltiazem D6 hydrochloride | 5MG | Chiralix |
| CX12657-10MG | Diltiazem D6 hydrochloride | 10MG | Chiralix |
| CX12657-25MG | Diltiazem D6 hydrochloride | 25MG | Chiralix |
| CX12732-5MG | (R)-Terbutaline hemisulfate | 5MG | Chiralix |
| CX12732-10MG | (R)-Terbutaline hemisulfate | 10MG | Chiralix |
| CX12732-25MG | (R)-Terbutaline hemisulfate | 25MG | Chiralix |
| CX13312-5MG | (+)-O-Desmethyl Tramadol D6 | 5MG | Chiralix |
| CX13312-10MG | (+)-O-Desmethyl Tramadol D6 | 10MG | Chiralix |
| CX13312-25MG | (+)-O-Desmethyl Tramadol D6 | 25MG | Chiralix |
| CX13425-1G | D-azidoserine tert-butyl ether CHA salt | 1G | Chiralix |
| CX13425-5G | D-azidoserine tert-butyl ether CHA salt | 5G | Chiralix |
| CX13619-10MG | N-Desmethyl Venlafaxine hydrochloride | 10MG | Chiralix |
| CX13619-25MG | N-Desmethyl Venlafaxine hydrochloride | 25MG | Chiralix |
| CX13619-50MG | N-Desmethyl Venlafaxine hydrochloride | 50MG | Chiralix |
| CX13745-1G | (R)-propargylglycinol hydrochloride | 1G | Chiralix |
| CX13745-2G | (R)-propargylglycinol hydrochloride | 2G | Chiralix |
| CX14080-10MG | N-Desmethyl Sildenafil | 10MG | Chiralix |
| CX14080-25MG | N-Desmethyl Sildenafil | 25MG | Chiralix |
| CX14080-50MG | N-Desmethyl Sildenafil | 50MG | Chiralix |
chiralix CX50506说明书
| TIS108 | |
| A strigolactone-biosynthesis inhibitor. |
| TIS108 | |
| 松果内酯生物合成抑制剂。 |
|
| 化学名称 | 6-苯氧基-1-苯基-2-（1 H -1,2,4-三唑-1-基）己-1- |
| CAS号 | [无法使用] |
| 结构体 | |
| 分子式 | C 20 H 21 N 3 O 2 |
| 分子量 | 335.40 |
| 纯度 | > 98％ |
| 附加信息 | 荆芥内酯生物合成抑制剂TIS108对拟南芥的影响。 伊藤，S。等。 植物信号。行为。，2013，Vol。8，第5号，e24193。 |
| 货号 | 数量 | 价格（欧元） |
|---|---|---|
| CX50506-10MG | 10毫克 | €180 |
| CX50506-50MG | 50毫克 | €690 |
| CX50506-100MG | 100毫克 | 1150欧元 |
chiralix CX48771说明书
CX48771-10MG
CAS编号1309283-30-4
化学名称2-（2-（（2,6-二氯-4-羟基苯基-1,2,3,4,5,6-13C6）氨基）-5-羟基苯基）乙酸
分子式C813C6H11Cl2NO3
分子量318.10
纯度>98%
Chiralix代理
chiralix常卖产品：
| 货号 | 品名 | 规格 | 品牌 |
| CX23880-5MG | rac-GR24 | 5 milligrams | Chiralix |
| CX48771-5MG | 4'-hydroxydiclofenac-13C6 | 5 milligrams | Chiralix |
| CX55029-2MG | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | 2MG | Chiralix |
| CX27716-5mg | 3-methyl-2H-furo[2,3-c]pyran-2-one | 5mg | Chiralix |
| mx7269-1mg | rac-GR24(strigolactone analog)独脚金内酯 | 1mg | Chiralix |
| CX23880-20MG | rac-GR24 | 20milligrams | Chiralix |
| BSA51546 | EnantioPak® BSA蛋白柱 | 5um,4.6*150mm | Chiralix |
| CX94973-5MG | 25-Hydroxyvitamin D3 3-Hemisuccinate | 5 milligrams | Chiralix |
| CX94877 | KAR2 | 10 milligrams | Chiralix |
| CX57163 | 13C6-cereulide | 2MG | Chiralix |
| CX57163-2MG | 13C6-cereulide | 2mg | Chiralix |
| CX34065-1MG | 25-OH vitamin D3-DPEG4-Biotin | 1MG | Chiralix |
| CX27716-25MG | KAR1 | 25 milligrams | Chiralix |
| CX64382-1MG | (±)-strigol | 1MG | Chiralix |
Chiralix致力于支持全球生命科学研究人员，提供一系列的构建块、参考标准、代谢物、杂质、稳定同位素标记化合物（2H、13C和15N）等。我们的大多数产品都有现货供应，我们对质量充满热情，是您专业研究化学品的可靠来源。
Chiralix代理
chiralix CX23880说明书
SDS_CX23880[PDF-159.82 KB]
规格
CAS号 76974-79-3
化学名称（3aR*，8bS*，E）-3-（（（R*）-4-甲基-5-氧代-2,5-二氢呋喃-2-基氧基）亚甲基）-3,3a，4,8b-四氢-2H-茚并[1,2-b]呋喃-2-酮
分子式C17H14O5
分子量298.29
纯度>98%
chiralix常卖产品：
| 货号 | 品名 | 规格 | 品牌 |
| CX23880-5MG | rac-GR24 | 5 milligrams | Chiralix |
| CX48771-5MG | 4'-hydroxydiclofenac-13C6 | 5 milligrams | Chiralix |
| CX55029-2MG | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | 2MG | Chiralix |
| CX27716-5mg | 3-methyl-2H-furo[2,3-c]pyran-2-one | 5mg | Chiralix |
| mx7269-1mg | rac-GR24(strigolactone analog)独脚金内酯 | 1mg | Chiralix |
| CX23880-20MG | rac-GR24 | 20milligrams | Chiralix |
| BSA51546 | EnantioPak® BSA蛋白柱 | 5um,4.6*150mm | Chiralix |
| CX94973-5MG | 25-Hydroxyvitamin D3 3-Hemisuccinate | 5 milligrams | Chiralix |
| CX94877 | KAR2 | 10 milligrams | Chiralix |
| CX57163 | 13C6-cereulide | 2MG | Chiralix |
| CX57163-2MG | 13C6-cereulide | 2mg | Chiralix |
| CX34065-1MG | 25-OH vitamin D3-DPEG4-Biotin | 1MG | Chiralix |
| CX27716-25MG | KAR1 | 25 milligrams | Chiralix |
| CX64382-1MG | (±)-strigol | 1MG | Chiralix |
| CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | 1ML | Chiralix |
| CX23880-100MG | 100 milligrams | 100MG | Chiralix |
Chiralix——手性分子专业供应商
Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供的研发服务，如复杂有机分子的合成等。
公司主要产品：
1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。
L-allysine ethylene acetal L/D-homopropargylglycine
L/D–bishomopropargylglycine (2S,5R)-5-hydroxypipecolic acid hydrochloride
(S/R)-4-oxopipecolic acid ethylene acetal (S)-5-oxopipecolic acid ethylene acetal
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid
(S)-β3-phenylalanine (S/R)-α-methyl-phenylglycine
D-tert-leucine
2、N-BOC保护的氨基酸骨架类
Boc-L-allysine ethylene acetal Boc-L-homopropargylglycine
Boc-L/D-bishomopropargylglycine CHA salt
(S)-Boc-β3-phenylalanine (S)-Boc-α-methyl-phenylglycine
Boc-D-tert-leucine
3、N-CBZ 保护的氨基酸骨架类
Cbz-L-allysine ethylene acetal Cbz-L-homopropargylglycine
Cbz-D-homopropargylglycine Cbz-L-bishomopropargylglycine CHA salt
Cbz-D-bishomopropargylglycine CHA salt (S)-Cbz-β3-phenylalanine
(S)-Cbz-α-methyl-phenylglycine CHA salt Cbz-D-tert-leucine CHA salt
4、N-FMOC 保护的氨基酸骨架类
Fmoc-L-allysine ethylene acetal Fmoc-L-homopropargylglycine
Fmoc-D-homopropargylglycine Fmoc-L-bishomopropargylglycine
Fmoc-D-bishomopropargylglycine Fmoc-cyclohexylglycine
Fmoc-D-cyclohexylglycine Fmoc-L-β-azidoalanine
Fmoc-L-γ-azidohomoalanine Fmoc-L-δ-azidoornithine
Fmoc-L-ε-azidolysine (S)-Fmoc-β3-phenylalanine
(S/R)-Fmoc-α-methyl-phenylglycine
Fmoc-D-tert-leucine
5、AZIDO氨基酸骨架类
4-azidobutanoic acid 5-azidopentanoic acid
6-azidohexanoic acid 7-azidoheptanoic acid
2-(azidomethyl)benzoic acid 3-(azidomethyl)benzoic acid
4-(azidomethyl)benzoic acid L-azidoalanine CHA salt
D-azidoalanine CHA salt L-azidoallylglycine CHA salt
D-azidoallylglycine CHA salt NG-Pmc-L-azidoarginine
L-azidoasparagine DCHA salt D-azidoasparagine DCHA salt
L/D-azidoaspartic acid mono-tert-butyl ester CHA salt
S-Trityl-L-azidocysteine CHA salt
L-azidoglutamic acid mono-tert-butyl ester CHA salt
D-azidoglutamic acid mono-tert-butyl ester CHA salt
L-azidoglutamine DCHA salt
D-azidoglutamine DCHA salt N-im-Trityl-L-azidohistidine CHA salt
L/D-azidoisoleucine CHA salt
L/D-azidoleucine CHA salt
L/D-azido-tert-leucine CHA salt
L/D-azidomethionine CHA salt
L/D-azidophenylalanine CHA salt
(S/R)-azido-α-methyl-phenylglycine
L/D-azidoserine CHA salt
L/D-azidoserine tert-butyl ether CHA salt
L-azidothreonine CHA salt D-azidothreonine CHA salt
L/D-azidothreonine tert-butyl ether CHA salt
L/D-azidotryptophan CHA salt
L/D-azidotyrosine CHA salt
L/D-azidotyrosine tert-butyl ether CHA salt
L-azidovaline CHA salt
Fmoc-L-β-azidoalanine Fmoc-L-γ-azidohomoalanine
Fmoc-L-δ-azidoornithine Fmoc-L-ε-azidolysine
6、β2氨基酸骨架类
(S/R)-β2-homoalanine HCl salt
(S/R)-β2-homoleucine HCl salt
(S/R)-β2-homophenylalanine HCl salt
(S/R)-β2-homovaline HCl salt
7、FMOC保护的β2氨基酸骨架类
(S/R)-Fmoc-β2-homoalanine
(S/R)-Fmoc-β2-homoleucine
(S/R)-Fmoc-β2-homophenylalanine
(S/R)-Fmoc-β2-homovaline
8、CHROMOGENIC 及FLUOROGENIC氨基酸
H-Arg(Boc)2-pNA H-Orn(Boc)-pNA
Fmoc-Orn-pNA · HCl H-Arg(Boc)2-AMC
H-Orn(Boc)-AMC Fmoc-Orn-AMC · HCl
H-Lys(Boc)-AMC Fmoc-Lys-AMC · HCl
Bis(H-Arg(Boc)2)-rhodamine 110 Bis(H-Orn(Boc))-rhodamine 110
9、氨基乙醇及其衍生产品
2-deoxystreptamine dihydrobromide
bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine
bis(N-Boc)-2-deoxystreptamine bis(N-Cbz)-2-deoxystreptamine
6,8a-diepi-castanospermine (S)-allylglycinol hydrochloride
(R)-allylglycinol hydrochloride (S)-propargylglycinol hydrochloride
(R)-propargylglycinol hydrochloride (S)-homopropargylglycinol hydrochloride
(R)-homopropargylglycinol hydrochloride (S)-bishomopropargylglycinol hydrochloride
(R)-bishomopropargylglycinol hydrochloride (2S,5R)-5-hydroxypipecolic acid hydrochloride
(5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid
10、CEREULIDE & 13C6-CEREULIDE（致吐毒素及其衍生品）
cereulide (50 µg/mL in acetonitrile)
Cereulide
13C6-cereulide (20 µg/mL in acetonitrile)
13C6-cereulide
11、STRIGOLACTONES & ANALOGUES（独脚金内酯及其类似物）
(rac)-GR24 (±)-strigol
(±)-5-deoxystrigol (±)-2'-epi-5-deoxystrigol
(±)-sorgolactone TIS108
4-Br debranone 4-CN debranone
Nijmegen-1
12、其它产品
Abamine oxalic acid salt RR6
2,2,2-trichloroethoxysulfonyl chloride
2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate
(S)-β3-phenylalanine methyl ester hydrochloride
(3R,4R)-3,4-dihydroxycyclohexa-1,5-dienecarboxylic acid
6-methylcyclohex-1-enecarboxylic acid